Literature DB >> 20121545

Intracerebral transplantation of mesenchymal stem cells derived from human umbilical cord blood alleviates hypoxic ischemic brain injury in rat neonates.

Guizhi Xia1, Xinru Hong, Xinmin Chen, Fenghua Lan, Guocheng Zhang, Lianming Liao.   

Abstract

AIMS: Fetal hypoxic-ischemic brain injury (HIBI) is a severe condition for which no effective therapy exists. In this study mesenchymal stem cells (MSCs) from human umbilical cord blood (UCB) of full-term newborns were isolated and intracerebrally transplanted into rat neonates after HIBI induction. Nerve function was assessed by the modified neurological severity scores (mNSS) to establish if MSCs could alleviate nerve injury.
RESULTS: Immunostaining showed the transplanted MSCs migrated to the hippocampus. Rats receiving MSCs treatment showed significant improvement in the mNSS when compared with controls. Also, histochemical study showed alleviation of brain tissue injury after MSCs treatment. Differentiation of MSCs to astrocytes, but not neurons, was observed.
CONCLUSIONS: The results indicate a beneficial effect of intracerebral transplantation of MSCs on the functional recovery of rat neonates with HIBI.

Entities:  

Mesh:

Year:  2010        PMID: 20121545     DOI: 10.1515/jpm.2010.021

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  20 in total

Review 1.  Stem cells for brain repair in neonatal hypoxia-ischemia.

Authors:  L Chicha; T Smith; R Guzman
Journal:  Childs Nerv Syst       Date:  2013-11-01       Impact factor: 1.475

2.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

Review 3.  Upcycling umbilical cords: bridging regenerative medicine with neonatology.

Authors:  Alvaro Moreira; Yasmeen Alayli; Saloni Balgi; Caitlyn Winter; Samuel Kahlenberg; Shamimunisa Mustafa; Peter Hornsby
Journal:  J Matern Fetal Neonatal Med       Date:  2017-11-27

Review 4.  Annual Research Review: The promise of stem cell research for neuropsychiatric disorders.

Authors:  Flora M Vaccarino; Alexander Eckehart Urban; Hanna E Stevens; Anna Szekely; Alexej Abyzov; Elena L Grigorenko; Mark Gerstein; Sherman Weissman
Journal:  J Child Psychol Psychiatry       Date:  2011-01-04       Impact factor: 8.982

Review 5.  From cord to caudate: characterizing umbilical cord blood stem cells and their paracrine interactions with the injured brain.

Authors:  Priya F Maillacheruvu; Lauren M Engel; Isaiah T Crum; Devendra K Agrawal; Eric S Peeples
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

6.  Term vs. preterm cord blood cells for the prevention of preterm brain injury.

Authors:  Jingang Li; Tamara Yawno; Amy Sutherland; Jan Loose; Ilias Nitsos; Beth J Allison; Robert Bischof; Courtney A McDonald; Graham Jenkin; Suzanne L Miller
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

Review 7.  Implantation of human umbilical cord mesenchymal stem cells for ischemic stroke: perspectives and challenges.

Authors:  Yingchen Li; Guoheng Hu; Qilai Cheng
Journal:  Front Med       Date:  2014-12-09       Impact factor: 4.592

8.  Neurobiology meets genomic science: the promise of human-induced pluripotent stem cells.

Authors:  Hanna E Stevens; Jessica Mariani; Gianfilippo Coppola; Flora M Vaccarino
Journal:  Dev Psychopathol       Date:  2012-11

9.  Transplantation of placenta-derived mesenchymal stem cells reduces hypoxic-ischemic brain damage in rats by ameliorating the inflammatory response.

Authors:  Hongfang Ding; Hui Zhang; Huifang Ding; Dong Li; Xinhao Yi; Xiaoxu Ma; Ruijuan Li; Mei Huang; Xiuli Ju
Journal:  Cell Mol Immunol       Date:  2015-12-28       Impact factor: 11.530

Review 10.  Human cord blood for the hypoxic-ischemic neonate.

Authors:  James Carroll
Journal:  Pediatr Res       Date:  2012-01-25       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.